Cytokinetics
CYTK
105 hedge funds and large institutions have $146M invested in Cytokinetics in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 32 reducing their positions, and 13 closing their positions.
279% more call options, than puts
Call options by funds: $4.32M | Put options by funds: $1.14M
46% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 13
6% more funds holding
Funds holding: 99 → 105 (+6)
9% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 32
4% more capital invested
Capital invested by funds: $140M → $146M (+$6.04M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$4.23M |
| 2 |
Morgan Stanley
New York
|
+$3.24M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$2.47M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.38M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.18M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.64M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.47M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.46M |
| 5 |
D.E. Shaw & Co
New York
|
-$811K |
CYTK Hedge Fund Activity: Q3 2015 in Review
105 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2015, worth a combined $146M — up 4.3% from $140M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CYTK positions and 13 closed out — a net gain of 6 holders — while 35 added to existing stakes and 32 trimmed.
The largest buyer was Citigroup, adding an estimated $4.23M. The largest seller was Fidelity Investments, cutting an estimated $7.18M.
- 105 institutional investors held Cytokinetics (CYTK) as of Q3 2015, up from 99 in Q2 2015.
- Funds reported $146M of Cytokinetics stock for Q3 2015, up 4.3% quarter-over-quarter.
- 19 funds opened new Cytokinetics positions in Q3 2015 and 13 closed out, a net change of +6 holders.
- The largest Cytokinetics buyer in Q3 2015 was Citigroup, an estimated $4.23M added.
- The largest Cytokinetics seller in Q3 2015 was Fidelity Investments, an estimated $7.18M sold.
Based on aggregated 13F filings for Q3 2015.